All Reports Events Blogs Videos
Showing 129 results
  • NEW
    Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • NEW
    Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • In the News
    May 14, 2026

    "Shared data allows the life sciences company to view the customer consistently across the organization, which means everyone is trying to drive the same outcomes for the customer instead of having a different view of the…
  • Blog
    May 13, 2026

    Since the launch of Claude Cowork, narratives suggesting that Artificial Intelligence (AI) will replace Software-as-a-Service (SaaS) platforms have gained significant momentum. We previously referred to this trend as the SaaSocalypse.  With the rise in vibe-coding and the rapidly advancing developer tools, many assume enterprises will increasingly build their own…
  • Blog
    April 09, 2026

    Veeva’s acquisition of Ostro reflects a shift in how life sciences engagement is evolving toward a model that is connected, conversational, and increasingly pull-based.  This shift matters because the industry’s commercial engagement model continues to face challenges. Life sciences…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Blog
    March 24, 2026

    Pharma Customer Relationship Management (CRM) is no longer a winner-takes-all market. For years, pharma CRM decisions were relatively straightforward, not because enterprises lacked strategic intent, but because the market offered limited real choice. That is now changing.  Since the onset of the COVID-19…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • See Us At
    Dec. 09, 2025

    Join us for an exclusive evening AR/analyst networking party to kick off the holiday season. It’s a great opportunity to connect, celebrate, and recognize excellence across the analyst and AR community.  Register now This special event will also include the…
  • Press Release
    Dec. 03, 2025

    Everest Group has announced the release of a new Viewpoint report, The Future of CRM in Pharma: A Decision Framework to Navigate the Post Veeva–Salesforce Era, designed to guide pharmaceutical companies through pivotal CRM platform decisions following the conclusion…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Viewpoint
    Sep. 26, 2025

    MedTech organizations are under increasing pressure to reimagine stakeholder engagement in response to increasing demand for personalized, connected experiences across the entire device life cycle. Functional silos, disparate technologies, and a lack of cross-functional alignment constrain…
  • Viewpoint
    Sep. 24, 2025

    Pharma organizations today face increasing complexities in delivering cohesive engagement to diverse stakeholders such as healthcare professionals, key opinion leaders, patients, and payers. The current model, built on fragmented platforms and siloed workflows, struggles to support…
  • Webinar Deck
    Aug. 29, 2025

    The life sciences industry has made significant strides in digitizing operations across clinical development and commercial engagement. However, many organizations still struggle with fragmented data, manual coordination, and delayed responses, hindering real-time decision-making. Systems of Execution…
  • Event
    Aug. 26, 2025

    The life sciences industry has made significant strides in digitizing operations across clinical development and commercial engagement. However, many organizations still struggle with fragmented data, manual coordination, and delayed responses, hindering real-time decision-making. Systems of Execution…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Provider Compendium
    Aug. 19, 2025

    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that…

Items per page